Anti-Hu CD105 PerCP-Cy™5.5

*Plánka L, Necas A, Srnec R, Rauser P, Starý D, Jancár J, Amler E, Filová E, Hlucilová J, Kren L, Gál P: Use of allogenic stem cells for the prevention of bone bridge formation in miniature pigs. Physiol Res. 2009;58 (6) :885-93., URL: https://www.ncbi.nlm.nih.gov/pubmed/19093735

*Zhu Y, Sun Y, Xie L, Jin K, Sheibani N, Greenberg DA: Hypoxic induction of endoglin via mitogen-activated protein kinases in mouse brain microvascular endothelial cells. Stroke. 2003 Oct;34 (10) :2483-8., URL: https://www.ncbi.nlm.nih.gov/pubmed/12947156?ordin, *Li C, Issa R, Kumar P, Hampson IN, Lopez-Novoa JM, Bernabeu C, Kumar S: CD105 prevents apoptosis in hypoxic endothelial cells. J Cell Sci. 2003 Jul 1;116 (Pt 13) :2677-85., URL: https://www.ncbi.nlm.nih.gov/pubmed/12746487?ordin, *Guo B, Slevin M, Li C, Parameshwar S, Liu D, Kumar P, Bernabeu C, Kumar S: CD105 inhibits transforming growth factor-beta-Smad3 signalling. Anticancer Res. 2004 May-Jun;24 (3a) :1337-45., URL: https://www.ncbi.nlm.nih.gov/pubmed/15274293?ordin, *Warrington K, Hillarby MC, Li C, Letarte M, Kumar S: Functional role of CD105 in TGF-beta1 signalling in murine and human endothelial cells. Anticancer Res. 2005 May-Jun;25 (3B) :1851-64., URL: https://www.ncbi.nlm.nih.gov/pubmed/16158917?ordin, *Piao M, Tokunaga O: Significant expression of endoglin (CD105), TGFbeta-1 and TGFbeta R-2 in the atherosclerotic aorta: an immunohistological study. J Atheroscler Thromb. 2006 Apr;13 (2) :82-9., URL: https://www.ncbi.nlm.nih.gov/pubmed/16733295?ordin